Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs Subcutaneous Ketamine for Acute Pain in ED
NCT05229055Phase 3Completed
- Sponsor
- Université de Monastir
- Start
- Apr 2023
- Primary completion
- May 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ketamine in acute pain, sponsored by Université de Monastir. Started Apr 2023; status: completed.
02
Drugs
ketamine
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05229055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05229055.